Catalyst
Slingshot members are tracking this event:
FDA Grants Tentative Approval to Intellipharmaceutics' (IPCI) Seroquel XR for Schizophrenia and Maniac/Mixed Episodes Associated with Bipolar Disorder
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| IPCI |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 07, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Tentative Approval, Fda, Seroquel Xr, Schizophrenia, Maniac/mixed Episodes, Bipolar Disorder
